Cytokeratin 5 Antikörper
(2 Referenzen)-
- Target Alle Cytokeratin 5 (KRT5) Antikörper anzeigen
- Cytokeratin 5 (KRT5) (Keratin 5 (KRT5))
-
Reaktivität
- Human
-
Wirt
-
Meerschweinchen
-
Klonalität
- Polyklonal
-
Konjugat
- Dieser Cytokeratin 5 Antikörper ist unkonjugiert
-
Applikation
- Western Blotting (WB), Immunohistochemistry (Paraffin-embedded Sections) (IHC (p)), Immunohistochemistry (Frozen Sections) (IHC (fro))
- Reinheit
- Stabilized antiserum
- Immunogen
- Cytokeratin 5 antibody was raised in guinea pig using recombinant human keratin K5 as the immunogen.
- Top Product
- Discover our top product KRT5 Primärantikörper
-
anti-Keratin 5 (KRT5) (AA 316-590) antibody
KRT5 Reaktivität: Human WB, IHC, ELISA, FACS Wirt: Maus Monoclonal 10C11E6 unconjugated
anti-Keratin 5 (KRT5) antibodyKRT5 Reaktivität: Human, Maus, Affe WB, IHC, ELISA, FACS, ICC Wirt: Maus Monoclonal 2C2 unconjugated
anti-Keratin 5 (KRT5) (AA 335-473) antibodyKRT5 Reaktivität: Ratte WB, IHC, IP, ICC Wirt: Kaninchen Polyclonal unconjugated
anti-Keratin 5 (KRT5) (AA 258-357) antibodyKRT5 Reaktivität: Human WB, IHC, ELISA, FACS, ICC Wirt: Maus Monoclonal 2C8E4 unconjugated
anti-Keratin 5 (KRT5) (AA 258-357) antibodyKRT5 Reaktivität: Human, Maus, Affe WB, IHC, ELISA, FACS, ICC Wirt: Maus Monoclonal 3D6D4 unconjugated
anti-Keratin 5 (KRT5) (AA 316-590) antibodyKRT5 Reaktivität: Human IHC, StM Wirt: Maus Monoclonal KRT5-3594 unconjugated
anti-Keratin 5 (KRT5) antibodyKRT5 Reaktivität: Human WB, IHC, IF, IP Wirt: Kaninchen Polyclonal unconjugated
anti-Keratin 5 (KRT5) (AA 1-273) antibodyKRT5 Reaktivität: Human WB, IHC, IHC (p) Wirt: Maus Monoclonal 4A7 unconjugated
anti-Keratin 5 (KRT5) (AA 163-471) antibodyKRT5 Reaktivität: Maus WB, IHC, IP, ICC Wirt: Kaninchen Polyclonal unconjugated
anti-Keratin 5 (KRT5) (AA 331-430) antibodyKRT5 Reaktivität: Human, Maus, Ratte WB, ELISA, FACS, IHC (p), IF (cc), IF (p), IHC (fro) Wirt: Kaninchen Polyclonal unconjugated
-
- Applikationshinweise
- IHC-F: 1:100, IHC-P: 1:50, WB: 1:5,000-1:10,000
- Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
- Format
- Liquid
- Konzentration
- Lot specific
- Buffer
- Suppleid as a liquid with 0.09 % NaN3 and 0.5 % BSA.
- Konservierungsmittel
- Sodium azide
- Vorsichtsmaßnahmen
- This product contains sodium azide as preservative. Although the amount of sodium azide is very small appropriate care must be taken when handling this product.
- Lagerung
- 4 °C
- Informationen zur Lagerung
- Store at 4 °C
-
-
: "Syngeneic animal models of tobacco-associated oral cancer reveal the activity of in situ anti-CTLA-4." in: Nature communications, Vol. 10, Issue 1, pp. 5546, (2020) (PubMed).
: "p73 regulates epidermal wound healing and induced keratinocyte programming." in: PLoS ONE, Vol. 14, Issue 6, pp. e0218458, (2019) (PubMed).
-
: "Syngeneic animal models of tobacco-associated oral cancer reveal the activity of in situ anti-CTLA-4." in: Nature communications, Vol. 10, Issue 1, pp. 5546, (2020) (PubMed).
-
- Target
- Cytokeratin 5 (KRT5) (Keratin 5 (KRT5))
- Andere Bezeichnung
- Cytokeratin 5 (KRT5 Produkte)
- Synonyme
- 3300001P10Rik antikoerper, AW146334 antikoerper, CK5 antikoerper, K5 antikoerper, Krt2-5 antikoerper, Tfip8 antikoerper, DDD antikoerper, DDD1 antikoerper, EBS2 antikoerper, KRT5A antikoerper, Sak57 antikoerper, ckii antikoerper, wu:fb02h09 antikoerper, wu:fj02d02 antikoerper, wu:fk78b12 antikoerper, zfCKII antikoerper, KRT75 antikoerper, CK-5 antikoerper, Keratin-5 antikoerper, keratin 5 antikoerper, Krt5 antikoerper, KRT5 antikoerper, krt5 antikoerper
-
